 
                The XBridge Premier Oligonucleotide BEH C18 Column, 300 Å, 2.5 µm, 2.1 X 100 mm, is used to separate oligonucleotides via ion-pairing reversed-phase (IP-RP) chromatography on UHPLC/HPLC systems. Each column incorporates Waters' BEH hybrid particle technology for unmatched pH and temperature stability and our MaxPeak Premier high performance surface technology for ultra-low non-specific adsorption. Stationary phase batches are also QC tested using the Waters MassPREP Oligonucleotide Standard to ensure lot-to-lot performance. Premier Oligonucleotide BEH Columns provide unmatched sensitivity, exquisite reproducibility, and excellent out-of-the-box performance. Columns with 130 Å pore size particles deliver industry leading performance for short-mer oligonucleotide separations, and new 300 Å pore size columns offer enhanced resolution for longer oligonucleotides.
| Chimie | C18 | 
| Mode de séparation | Phase inverse | 
| Particules de support | Hybrid | 
| pH Range Min | 1 pH | 
| pH Range Max | 12 pH | 
| Maximum Pressure | 18000 psi (1240 Bar) | 
| Endcapped | Oui | 
| Silanol Activity | Low | 
| Particle Shape | Spherical | 
| Granulométrie | 2.5 µm | 
| Endfitting Type | Parker-style | 
| Taille des pores | 300 Å | 
| QC Tested | Oligonucleotide | 
| Format | Colonne | 
| Système | UPLC | 
| Technologie de particules | BEH | 
| Technique | LC | 
| Classification USP | L1 | 
| Diamètre interne | 2.1 mm | 
| Longueur | 100 mm | 
| Carbon Load | 18 % | 
| eCord | Oui | 
| UNSPSC | 41115711 | 
| Application | Oligonucléotide, Gene Therapeutics | 
| Gamme | ACQUITY | 
| Type de produit | Colonnes | 
| Units per Package | 1 pk | 
